Loading clinical trials...
Loading clinical trials...
Obesity is now becoming a worldwide serious problem. Obesity is associated with a spectrum of severe diseases, including diabetes, cardiovascular diseases, and cancers. Lipocalin 2 (LCN2), also known ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Shen Qu
NCT06377358 · Obesity, Visceral, Obesity; Endocrine
NCT04100616 · Overweight and Obesity, Overweight or Obesity, and more
NCT04305093 · Obesity; Endocrine, Hormone Disturbance
NCT05322551 · Obesity; Endocrine, Diabete Type 2, and more
NCT04019860 · Obesity; Endocrine
Department of Endocrinology, Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions